Welcome Remarks

Arturo Molina,MS '83, MD '83, PD '86, PD '89

President, Stanford Medical Alumni Association

Dr. Molina is Chief Medical Officer at Sutro Biopharma.  Previously, he was Vice President, Oncology Scientific Innovation at Janssen R & D (Johnson and Johnson, JNJ). While at JNJ he was responsible for the clinical development and New Drug Application for abiraterone (Zytiga®), which is now approved for metastatic prostate cancer in more than 100 countries. He was Chief Medical Officer/EVP at Cougar Biotechnology, which was acquired by JNJ in 2009. Arturo also worked at IDEC, then Biogen-IDEC, ultimately becoming Head, Oncology Clinical Development. In collaboration with Genentech, he led the clinical Supplemental Biologics License Application (sBLA) filing activities resulting in FDA approval of Rituxan® in two first-line indications in 2006: follicular lymphoma and diffuse B-cell lymphoma. 

From 1991-2002, Dr. Molina was a faculty physician in Hematology/Bone Marrow Transplantation and Medical Oncology/Therapeutics Research at the City of Hope (COH) Comprehensive Cancer Center, where he became an Adjunct Professor, member of the COH Medical Group Board of Directors and President-Elect of the COH Medical Staff. Arturo received his MD and MS (Physiology) from Stanford University, and completed residency in Internal Medicine and fellowships in Medical Oncology, Biological Science, and Bone Marrow Transplantation, all at Stanford.

Arturo was an undergraduate at the University of Texas at Austin where he received a BS in Zoology (Honors) and BA in Psychology (High Honors).

Daniel Kraft, MD '96, Fellow '01

Faculty Chair for Medicine, Singularity University

Founder and Chair, Exponential Medicine

Daniel Kraft is a Stanford and Harvard trained physician-scientist, entrepreneur, inventor, and innovator with more than 25 years of experience in clinical practice, biomedical research, and health care innovation. He has served as faculty chair for medicine at Singularity University since its inception, and is the founder and chair of Exponential Medicine, a program that explores convergent, rapidly developing technologies and their potential in biomedicine and health care. Daniel is a graduate of Brown University and Stanford University School of Medicine and completed his residency at the Massachusetts General Hospital. He founded RegenMed Systems; has multiple digital health, medical device, immunology, and stem cell related patents; and has served on the faculty at Stanford and UCSF. 

LATHA PALANIAPPAN, MD, MS ’01 

Professor of Medicine; Co-Director, Center for Asian Health Research and Education, Stanford University School of Medicine

Latha Palaniappan is an internist and clinical researcher studying diverse populations, chronic disease, and prevention.  At Palo Alto Medical Foundation, she was the co-founder of PRANA, a South Asian Wellness program, and at Stanford she co-founded the Center for Asian Health Research and Education (CARE). In addition to recent diabetes research, she is currently working on precision genetic and pharmacogenetic testing in Stanford primary care clinics. She is also the faculty director of the Precision Health Biobank, a population-based database designed to accelerate genetic and other -omics discovery. Latha received her BA and MD degrees from the University of Michigan and an MS in Epidemiology at Stanford University.

STEVE COLLINS, PHD 

Associate Professor of Mechanical Engineering; Director, Stanford Biomechatronics Lab, Stanford University. 

Steve Collins is an expert in the design of exoskeletons and prosthetic limbs. He received his BS from Cornell and his PhD from the University of Michigan. Prior to joining Stanford, he was a research fellow at T.U.Delft and a professor of Mechanical Engineering and Robotics at Carnegie Mellon. He now directs the Stanford Biomechatronics Laboratory, where his team develops customized exoskeletons and prostheses for people with stroke and amputation, including devices with the largest improvements in speed and energy economy to date. His honors include student-voted Professor of the Year and membership on the Editorial Board of Science Robotics.

DENNIS WALL, PHD, FELLOW ’03 

Associate Professor of Pediatrics; Associate Professor of Biomedical Data Science, Stanford University School of Medicine

Dennis Wall leads a lab that is focused on pediatric innovation, using biomedical informatics to disentangle complex conditions including autism and related developmental delays. At both Harvard and Stanford, he has pioneered detection and treatment of neurodevelopmental disorders in children using machine learning and artificial intel-ligence, including wearable devices such as Google Glass. He has received numerous awards, including the Fred R. Cagle Award for Outstanding Achievement in Biology and the Slifka/Ritvo Clinical Innovation in Autism Research Award. Dennis completed his PhD at the University of California, Berkeley and a fellowship in Computational Genetics at Stanford University.

JONATHAN H. CHEN, MD, PHD, RESIDENT ’14 

Assistant Professor of Medicine, Biomedical Informatics Research and Hospital Medicine, Stanford University School of Medicine

Jonathan Chen is a physician-scientist and practicing clinician who seeks to combine human and artificial intelligence approaches in medicine to deliver better care than what either can do alone. His research integrates informatic solu-tions and real-world clinical data streams like electronic medical records with machine learning and data analytics to solve today’s health-care challenges. Jonathan has received numerous awards and recognition from the NIH Big Data 2 Knowledge initiative, National Library of Medicine, American Medical Informatics Association, Yearbook of Medical Informatics, and American College of Physicians, among others. He completed medical and computer science gradu - ate training at UC Irvine, and his residency at Stanford with a VA research fellowship in Medical Informatics.

DAVID MYUNG, MS ’06, PHD ’08, MD ’11 

Assistant Professor of Ophthalmology, Stanford University School of Medicine

David Myung is an attending physician at the VA Palo Alto Health Care System specializing in cataract and corneal surgery and external diseases of the eye. He is also the co-director of the Ophthalmic Innovation Program, a fellowship in the development of new eye care technologies, as well as the director of Tele-Ophthalmology at the Byers Eye Institute. His research focuses on ophthalmic regenerative medicine through tissue engineering, and global health and quality improvement through mobile technologies and telemedicine. David earned an MS and PhD in Chemical Engineering as well as his MD, residency, and fellowship training  at Stanford.

ERIC YABLONKA, MBA 

Chief Information Officer; Associate Dean, Stanford Health Care and Stanford University School of Medicine

Eric Yablonka has more than 30 years of experience leading hospital operations and information systems. In 2017, he joined Stanford Health Care, where he is responsible for all information technology functions, information security, and biomedical engineering. Prior to Stanford, Eric served as vice president and CIO of University of Chicago Medicine. He has been honored to receive the CHIME/HIMSS and the Executives Club of Chicago CIO of the Year awards. His teams have been recognized with numerous awards, including: CIO100, Most Wired, Information Week Elite 100, CHEF Innovation, and SIM/AITP Most Effective Team. Eric earned an MBA from Michigan State University and is a graduate of State University of New York College.

STEVEN HERSHMAN, PHD 

Director, mHealth; Division of Cardiovascular Medicine, Stanford University School of Medicine

Steve Hershman is a scientist, technologist, and entrepreneur. He earned his PhD in Systems Biology in the lab of Vamsi Mootha, MD, at Massachusetts General Hospital/Harvard Medical School applying targeted sequencing to a cohort of individuals afflicted with mitochondrial disease. After graduate school, Steve cofounded LifeMap Solutions, which was involved in the launch of the ResearchKit study Asthma Health and continued development of MyHeart Counts. At Stanford, Steve leads the day-to-day operations of MyHeart Counts as well as other digital health and -omics projects. Steve also holds BA, MS, and MSE degrees from the University of Pennsylvania.

KATE ROSENBLUTH, BS ’04, PHD, PD ’15

Founder and Chief Scientific Officer, Cala Health

Kate Rosenbluth is the founder of Cala Health, a bioelectronic medicines company transforming the standard of care for chronic disease. The company’s wearable neuromodulation therapies merge innovations in neuroscience and technology. Prior to spinning Cala out from the Stanford Biodesign fellowship, she developed cutting-edge neurotherapies with Brainlab, Autonomic Technologies, and Genentech, and completed a postdoctoral fellowship at UCSF in Neurosurgery following her PhD in Bioengineering at UC Berkeley and UCSF. Kate has authored more than 60 patents and peer-reviewed publications. Kate currently serves on the McKinsey Women’s Executive Roundtable and the Strategy Group of the Center for Healthcare Innovation.

LLOYD B. MINOR, MD 

Carl and Elizabeth Naumann Dean, Stanford University School of Medicine

Lloyd B. Minor is a scientist, surgeon, and academic leader. He has served as dean since December 2012. In addition, he is a professor of Otolaryngology—Head and Neck Surgery and (by courtesy) of Neurobiology and Bioengineering at Stanford University. Dr. Minor plays an integral role in setting strategy for the clinical, research, and teaching missions of Stanford Medicine. He also oversees the quality of Stanford Medicine’s physician practices and growing clinical networks. With his leadership, Stanford Medicine has established a strategic vision to lead the biomedical revolution in Precision Health, a fundamental shift to more proactive and personalized health care.

ODETTE A. HARRIS, MD ’96, RESIDENT ’03, MPH 

Professor of Neurosurgery; Director, Brain Injury 

Vice Chair, Diversity, Department of Neurosurgery, Stanford University School of Medicine

The RISE (Reach, Inspire, Serve, Engage) Award will be presented to Dr. Harris in recognition of her exceptional dedication to nurturing Stanford Medicine and its alumni community through acts of leadership, volunteerism, mentoring, and teaching.

Dean's Reception - 6:00 PM

*Reunion class photos will be taken during this reception

All alumni are invited to attend this evening reception hosted by Dean Lloyd B. Minor. Raise a glass to Stanford University School of Medicine and to your fellow alumni! 

Reunion Dinner - 7:00 PM

Before Alumni Day 2020 draws to a close, conclude the evening alongside classmates at an elegant dinner in honor of all reunion year alumni.

This year’s MD reunion alumni include the classes of 1950, 1955, 1960, 1965, 1970, 1975, 1980, 1985, 1990, 1995, 2000, 2005, 2010, and 2015. Reunions for  MSTP alumni, PhD alumni, other School of Medicine degreed alumni, residents, postdocs, and fellows will also be celebrated.

Seating will be assigned based on year of graduation for MD alumni. Other alumni will be seated by program (MSTP, PhD, Postdoc, Fellow, Resident, etc.). If you have any specific seating or dietary requests, please be sure to mention them when you register.